Who Paid My Doc
Phase IIA 2L Prostate Ipi Nivo Combo
Research payments
$3,276,431
Through program year 2021, $3,276,431 in research payments was reported against Phase IIA 2L Prostate Ipi Nivo Combo, across 58 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $1,515,817 | 21 |
| 2020 | Research | $1,267,246 | 18 |
| 2019 | Research | $493,368 | 19 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Vivek Narayan Philadelphia, PA Named on 9 payments
- Padmanee Sharma Houston, TX Named on 7 payments
- Akash Patnaik Chicago, IL Named on 4 payments
- Maged Khalil Allentown, PA Named on 4 payments
- Russell Pachynski Saint Louis, MO Named on 4 payments
- Steven McCune Marietta, GA Named on 3 payments
- Samith Kochuparambil Minneapolis, MN Named on 2 payments
- Ian Schnadig Tigard, OR Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.